Skip to main content
PRFX
NASDAQ Life Sciences

PRF Signs Non-Binding Term Sheet to Sell GridFeed to Dotz for US$1.0M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.771
Mkt Cap
$2.163M
52W Low
$0.691
52W High
$7.95
52W Position info
11% above low
Off High info
90% below high
Rel. Volume info
9.9× avg
Market data snapshot near publication time

PRFX is trading near its 52-week low of $0.691 (11% above the low) on elevated volume (9.9× avg).

Summary

PRF signed a non-binding term sheet for Dotz to exclusively license and ultimately buy the GridFeed/DeepSolar platform for US$1.0 million, while PRF invests US$250,000 into Dotz's A$2.0 million placement. The deal would let PRF refocus on its OcuRing-K Phase 2 trial and healthcare programs.


Key Events · M&A and Partnerships · PRFX

  • Term Sheet Signed With Dotz Nano

    A non-binding term sheet would have Dotz exclusively license GridFeed from closing and acquire the DeepSolar/GridFeed platform for US$1.0 million.

  • Payment Tied to IP Transfer

    Ownership of the platform and its intellectual property transfers to Dotz once US$650,000 of the purchase price has been paid.

  • PRF Takes Dotz Equity Stake

    PRF would invest US$250,000 to participate in Dotz's recently announced A$2.0 million placement, keeping exposure to GridFeed's commercialization.

  • Deal Is Non-Binding

    Completion is subject to due diligence, approval by both boards of directors and execution of definitive agreements, so no proceeds are assured.


Analysis · PRFX · Life Sciences

PRF is exiting the energy software business it has been building since acquiring DeepSolar in March 2025. Under the terms, Dotz would take an exclusive license at closing and pay US$1.0 million in total, with ownership of the platform and its IP transferring once US$650,000 has been paid. PRF also puts US$250,000 into Dotz's A$2.0 million placement, so shareholders keep a stake in whatever Dotz builds. Because the deal is non-binding and requires due diligence, both boards and definitive agreements, the cash is not assured. Strategically, it narrows PRF to healthcare: the company says it will direct resources to LayerBio and the OcuRing-K Phase 2 trial, which it expects to start enrolling patients in before year-end 2026, against roughly US$11.0 million of preliminary unaudited cash at September 30, 2026.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PRFX was trading at $0.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $0.69 to $7.95. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRFX - Latest Insights

PRFX
Nov 13, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7834
Real-time Price: $0.635 info
Change: -$0.1484 (-19%) info
Market Cap: $1.971M info
PRFX
Nov 12, 2026, 4:31 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.7354
Real-time Price: $0.635 info
Change: -$0.1004 (-14%) info
Market Cap: $1.971M info
PRFX
Nov 12, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.786
Real-time Price: $0.635 info
Change: -$0.151 (-19%) info
Market Cap: $1.971M info
PRFX
Nov 05, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7588
Real-time Price: $0.635 info
Change: -$0.1238 (-16%) info
Market Cap: $1.971M info
PRFX
Nov 03, 2026, 4:01 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.711
Real-time Price: $0.635 info
Change: -$0.076 (-11%) info
Market Cap: $1.971M info